ArticleProceedings of the National Academy of Sciences of the United States of America2025
Acyl-CoA-binding protein as a driver of pathological aging.
Abstract read
In one paragraph
Article in Proceedings of the National Academy of Sciences of the United States of America, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed.
- The long-lived immune system of centenarians.Nature reviews. Immunology · 2026Review
- Cell death-induced release of the pro-aging protein acyl CoA binding protein (ACBP) into the circulation.Cell death and differentiation · 2026Article
- Multicellular senescence programs in the aged heart.Journal of molecular and cellular cardiology plus · 2026Review
- Increased WNT10B/FOXO6 signaling promotes cell fate transition in renal tubular cells to aggravate renal inflammation and fibrosis.Nature communications · 2026Article
- Acyl-CoA-binding protein (ACBP): a poor-prognosis biomarker in sepsis and a target for disease mitigation.Signal transduction and targeted therapy · 2026Article
- Senescent hepatic stellate cells drive inflammation and disease progression in MASH (Review).Experimental and therapeutic medicine · 2026Review
- Neutralization of acyl-CoA-binding protein attenuates glucocorticoid-mediated suppression of cancer immunosurveillance.Proceedings of the National Academy of Sciences of the United States of America · 2026Article
- Effects of Ritonavir, Lopinavir, and Alcohol on ABC Transporters and Secretion of Bile Acid and Bilirubin in Senescent Hepatocytes.International journal of molecular sciences · 2026Article
- Stress management by benzodiazepines in septic shock and critical illness: mechanistic and clinical evidence supporting alternative sedative strategies.Cell stress · 2026Article
- Article
- ACBP/DBI Neutralization Stimulates Anticancer Immune Responses by Upregulating Lamin A in T Cells.ImmunoTargets and therapy · 2026Article
- Increased plasma concentrations of acyl-coenzyme A binding protein (ACBP) predict future lung cancer development in smokers at risk of cardiovascular disease.Molecular cancer · 2025Article
- Pathological aging is alleviated by neutralization of the autophagy-repressive tissue hormone DBI/ACBP.Autophagy · 2025Article
- Acyl-CoA-binding protein as a driver of pathological aging.Proceedings of the National Academy of Sciences of the United States of America · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
26 authors.
Léa Montégut *Team Metabolism, Cancer & Immunity, Centre de Recherche des Cordeliers, Equipe Labellisée par la Ligue Contre le Cancer, Université Paris Cité, Sorbonne Université, Inserm U1138, Institut Universitaire de France, Paris 76006, France.ORCID 0000-0003-4778-4757
Flavia Lambertucci *Team Metabolism, Cancer & Immunity, Centre de Recherche des Cordeliers, Equipe Labellisée par la Ligue Contre le Cancer, Université Paris Cité, Sorbonne Université, Inserm U1138, Institut Universitaire de France, Paris 76006, France.
Lucas Moledo-NodarDepartamento de Bioquímica y Biología Molecular, Instituto Universitario de Oncología, Universidad de Oviedo, Oviedo 33007, Spain.ORCID 0009-0000-5320-489X
Carmen Fiuza-LucesPhysical Exercise and Pediatric Cancer Research Group, Research Institute of the Hospital, Madrid 28041, Spain.ORCID 0000-0001-8131-7007
Carlos Rodríguez-LópezCentro de Investigación Biomédica en Red de Fragilidad y Envejecimiento Saludable, Instituto de Salud Carlos III, Madrid 28029, Spain.ORCID 0000-0001-7545-7476
Jose Antonio Serra-RexachCentro de Investigación Biomédica en Red de Fragilidad y Envejecimiento Saludable, Instituto de Salud Carlos III, Madrid 28029, Spain.ORCID 0000-0003-1698-0624
Sylvie LachkarTeam Metabolism, Cancer & Immunity, Centre de Recherche des Cordeliers, Equipe Labellisée par la Ligue Contre le Cancer, Université Paris Cité, Sorbonne Université, Inserm U1138, Institut Universitaire de France, Paris 76006, France.ORCID 0000-0002-8169-140X
Omar MotiñoTeam Metabolism, Cancer & Immunity, Centre de Recherche des Cordeliers, Equipe Labellisée par la Ligue Contre le Cancer, Université Paris Cité, Sorbonne Université, Inserm U1138, Institut Universitaire de France, Paris 76006, France.
Mahmoud AbdellatifTeam Metabolism, Cancer & Immunity, Centre de Recherche des Cordeliers, Equipe Labellisée par la Ligue Contre le Cancer, Université Paris Cité, Sorbonne Université, Inserm U1138, Institut Universitaire de France, Paris 76006, France.ORCID 0000-0002-5042-9054
Sylvère DurandTeam Metabolism, Cancer & Immunity, Centre de Recherche des Cordeliers, Equipe Labellisée par la Ligue Contre le Cancer, Université Paris Cité, Sorbonne Université, Inserm U1138, Institut Universitaire de France, Paris 76006, France.
Fanny AprahamianTeam Metabolism, Cancer & Immunity, Centre de Recherche des Cordeliers, Equipe Labellisée par la Ligue Contre le Cancer, Université Paris Cité, Sorbonne Université, Inserm U1138, Institut Universitaire de France, Paris 76006, France.ORCID 0000-0002-2457-8435
Vincent CarbonnierTeam Metabolism, Cancer & Immunity, Centre de Recherche des Cordeliers, Equipe Labellisée par la Ligue Contre le Cancer, Université Paris Cité, Sorbonne Université, Inserm U1138, Institut Universitaire de France, Paris 76006, France.ORCID 0000-0002-2795-5013
Delphine Le CorreTeam Personalized Medicine, Phamacogenomics and Therapeutic Optimization, Centre de Recherche des Cordeliers, Equipe Labellisée par la Ligue Contre le Cancer, Université Paris Cité, Sorbonne Université, Inserm U1138, Institut Universitaire de France, Paris 75006, France.
Sophie Mouillet-RichardTeam Personalized Medicine, Phamacogenomics and Therapeutic Optimization, Centre de Recherche des Cordeliers, Equipe Labellisée par la Ligue Contre le Cancer, Université Paris Cité, Sorbonne Université, Inserm U1138, Institut Universitaire de France, Paris 75006, France.ORCID 0000-0002-8950-1949
Hui ChenTeam Metabolism, Cancer & Immunity, Centre de Recherche des Cordeliers, Equipe Labellisée par la Ligue Contre le Cancer, Université Paris Cité, Sorbonne Université, Inserm U1138, Institut Universitaire de France, Paris 76006, France.ORCID 0000-0002-1260-8617
Allan SauvatTeam Metabolism, Cancer & Immunity, Centre de Recherche des Cordeliers, Equipe Labellisée par la Ligue Contre le Cancer, Université Paris Cité, Sorbonne Université, Inserm U1138, Institut Universitaire de France, Paris 76006, France.ORCID 0000-0001-7076-8638
Yanbing DongTeam Metabolism, Cancer & Immunity, Centre de Recherche des Cordeliers, Equipe Labellisée par la Ligue Contre le Cancer, Université Paris Cité, Sorbonne Université, Inserm U1138, Institut Universitaire de France, Paris 76006, France.ORCID 0009-0006-4438-6162
Sijing LiTeam Metabolism, Cancer & Immunity, Centre de Recherche des Cordeliers, Equipe Labellisée par la Ligue Contre le Cancer, Université Paris Cité, Sorbonne Université, Inserm U1138, Institut Universitaire de France, Paris 76006, France.ORCID 0009-0003-1535-6050
Yan RongTeam Metabolism, Cancer & Immunity, Centre de Recherche des Cordeliers, Equipe Labellisée par la Ligue Contre le Cancer, Université Paris Cité, Sorbonne Université, Inserm U1138, Institut Universitaire de France, Paris 76006, France.
Federico PietrocolaDepartment of Cell and Molecular Biology, Karolinska Institute, Solna, Stockholm 17177, Sweden.
Pierre Laurent-PuigTeam Personalized Medicine, Phamacogenomics and Therapeutic Optimization, Centre de Recherche des Cordeliers, Equipe Labellisée par la Ligue Contre le Cancer, Université Paris Cité, Sorbonne Université, Inserm U1138, Institut Universitaire de France, Paris 75006, France.ORCID 0000-0001-8475-5459
Carlos López-OtínTeam Metabolism, Cancer & Immunity, Centre de Recherche des Cordeliers, Equipe Labellisée par la Ligue Contre le Cancer, Université Paris Cité, Sorbonne Université, Inserm U1138, Institut Universitaire de France, Paris 76006, France.ORCID 0000-0001-6964-1904
Isabelle MartinsTeam Metabolism, Cancer & Immunity, Centre de Recherche des Cordeliers, Equipe Labellisée par la Ligue Contre le Cancer, Université Paris Cité, Sorbonne Université, Inserm U1138, Institut Universitaire de France, Paris 76006, France.ORCID 0000-0003-0885-613X
Clea Barcena *Departamento de Bioquímica y Biología Molecular, Instituto Universitario de Oncología, Universidad de Oviedo, Oviedo 33007, Spain.ORCID 0000-0002-7452-2536
Alejandro Lucia *Physical Exercise and Pediatric Cancer Research Group, Research Institute of the Hospital, Madrid 28041, Spain.
Guido Kroemer *Team Metabolism, Cancer & Immunity, Centre de Recherche des Cordeliers, Equipe Labellisée par la Ligue Contre le Cancer, Université Paris Cité, Sorbonne Université, Inserm U1138, Institut Universitaire de France, Paris 76006, France.ORCID 0000-0002-9334-4405
Funding
No grant is acknowledged in the PubMed record.
Abstract
The tissue hormone acyl coenzyme A-binding protein (ACBP, encoded by the gene
Indexed as
AgingDiazepam Binding InhibitorAnimalsAntibodies, MonoclonalCellular SenescenceCisplatinDoxorubicinHumansMaleMiceAntibodies, MonoclonalCisplatinDiazepam Binding InhibitorDoxorubicinagingautophagychemotherapykidney injurysenescence
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.